244 related articles for article (PubMed ID: 32821381)
1. Chloroquine and hydroxychloroquine as a repurposed agent against COVID-19: a narrative review.
Acharya Y; Sayed A
Ther Adv Infect Dis; 2020; 7():2049936120947517. PubMed ID: 32821381
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
Gasmi A; Peana M; Noor S; Lysiuk R; Menzel A; Gasmi Benahmed A; Bjørklund G
Appl Microbiol Biotechnol; 2021 Feb; 105(4):1333-1343. PubMed ID: 33515285
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review.
Saghir SAM; AlGabri NA; Alagawany MM; Attia YA; Alyileili SR; Elnesr SS; Shafi ME; Al-Shargi OYA; Al-Balagi N; Alwajeeh AS; Alsalahi OSA; Patra AK; Khafaga AF; Negida A; Noreldin A; Al-Amarat W; Almaiman AA; El-Tarabily KA; Abd El-Hack ME
Ther Clin Risk Manag; 2021; 17():371-387. PubMed ID: 33953559
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19.
Ho TC; Wang YH; Chen YL; Tsai WC; Lee CH; Chuang KP; Chen YA; Yuan CH; Ho SY; Yang MH; Tyan YC
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33671315
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine and hydroxychloroquine provoke arrhythmias at concentrations higher than those clinically used to treat COVID-19: A simulation study.
Okada JI; Yoshinaga T; Washio T; Sawada K; Sugiura S; Hisada T
Clin Transl Sci; 2021 May; 14(3):1092-1100. PubMed ID: 33404133
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine and QTc prolongation in patients with COVID-19: A systematic review and meta-analysis.
Agstam S; Yadav A; Kumar-M P; Gupta A
Indian Pacing Electrophysiol J; 2021; 21(1):36-43. PubMed ID: 33075484
[TBL] [Abstract][Full Text] [Related]
8. Review of Hydroxychloroquine Cardiotoxicity: Lessons From the COVID-19 Pandemic.
Gagnon LR; Sadasivan C; Yogasundaram H; Oudit GY
Curr Heart Fail Rep; 2022 Dec; 19(6):458-466. PubMed ID: 36167917
[TBL] [Abstract][Full Text] [Related]
9. Risk versus Benefit of Using Hydroxychloroquine to Treat Patients with COVID-19.
Zhanel GG; Zhanel MA; Boreskie KF; Lynch JP; Karlowsky JA
Can J Infect Dis Med Microbiol; 2021; 2021():5942366. PubMed ID: 34557260
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Chloroquine and Hydroxychloroquine on ACE2-Related Coronavirus Pathology and the Cardiovascular System: An Evidence-Based Review.
Chen L; Chen H; Dong S; Huang W; Chen L; Wei Y; Shi L; Li J; Zhu F; Zhu Z; Wang Y; Lv X; Yu X; Li H; Wei W; Zhang K; Zhu L; Qu C; Hong J; Hu C; Dong J; Qi R; Lu D; Wang H; Peng S; Hao G
Function (Oxf); 2020; 1(2):zqaa012. PubMed ID: 38626250
[TBL] [Abstract][Full Text] [Related]
11. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine.
Bakadia BM; He F; Souho T; Lamboni L; Ullah MW; Boni BO; Ahmed AAQ; Mukole BM; Yang G
Biomed Pharmacother; 2021 Jan; 133():111008. PubMed ID: 33227708
[TBL] [Abstract][Full Text] [Related]
13. Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.
Mittal N; Mittal R; Gupta MC; Kaushal J; Chugh A; Khera D; Singh S
J Family Med Prim Care; 2021 Jun; 10(6):2126-2139. PubMed ID: 34322403
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso.
Rouamba T; Ouédraogo E; Barry H; Yaméogo NV; Sondo A; Boly R; Zoungrana J; Ouédraogo AR; Tahita MC; Poda A; Diendéré AE; Ouedraogo AS; Valea I; Traoré I; Tarnagda Z; Drabo MK; Tinto H;
Int J Infect Dis; 2022 May; 118():224-229. PubMed ID: 35227869
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine/chloroquine in patients with COVID-19 in Wuhan, China: a retrospective cohort study.
Chen Z; Liu A; Cheng Y; Wang X; Xu X; Huang J; Ma Y; Gao M; Huang C
BMC Infect Dis; 2021 Aug; 21(1):805. PubMed ID: 34384388
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and COVID-19-A systems biology model uncovers the drug's detrimental effect on autophagy and explains its failure.
Kapuy O; Korcsmáros T
PLoS One; 2022; 17(4):e0266337. PubMed ID: 35390060
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane chromatography for the analysis of the interaction between chloroquine and hydroxychloroquine with ACE2 receptors.
Fu J; Jia Q; Zhou H; Zhang L; Wang S; Liang P; Lv Y; Han S
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122469. PubMed ID: 33310480
[TBL] [Abstract][Full Text] [Related]
18. Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
Zhao Y; Zhang J; Zheng K; Thai S; Simpson RJ; Kinlaw AC; Xu Y; Wei J; Cui X; Buse JB; Stürmer T; Wang T
Drugs Real World Outcomes; 2022 Jun; 9(2):231-241. PubMed ID: 35386046
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety.
Takla M; Jeevaratnam K
Saudi Pharm J; 2020 Dec; 28(12):1760-1776. PubMed ID: 33204210
[TBL] [Abstract][Full Text] [Related]
20. Oxidative Stress, Proton Fluxes, and Chloroquine/Hydroxychloroquine Treatment for COVID-19.
Klouda CB; Stone WL
Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32967165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]